Alpha Tau Medical Ltd.
DRTS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001871321
In the last 90 days, Alpha Tau Medical Ltd. insiders filed 0 open-market purchases and 6 sales; 74 institutions reported holding it in 13F filings for Q2 2026, worth $100.1M in total; ARK Invest is the only superinvestor holding it.
Other share classesDRTSW
13F holders, Q4 2022
Institutional positions in Alpha Tau Medical Ltd. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 14
- −4 vs. Q3 2022
- Shares held
- 544.0K
- −153.4K (−22.0%) vs. Q3 2022
- Total value
- $1.70M
- −$2.31M (−57.7%) vs. Q3 2022
- New holders
- 3
- 2 more added
- Sold out
- 7
- 3 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DRTS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 74 | $100.1M |
| Q1 2026 | 53 | $29.1M |
| Q4 2025 | 35 | $11.9M |
| Q3 2025 | 31 | $8.26M |
| Q2 2025 | 24 | $4.95M |
| Q1 2025 | 23 | $2.94M |
| Q4 2024 | 21 | $3.03M |
| Q3 2024 | 23 | $2.23M |
| Q2 2024 | 24 | $3.25M |
| Q1 2024 | 27 | $5.35M |
| Q4 2023 | 26 | $5.51M |
| Q3 2023 | 23 | $3.65M |
| Q2 2023 | 20 | $4.11M |
| Q1 2023 | 16 | $1.87M |
| Q4 2022 | 14 | $1.70M |
| Q3 2022 | 18 | $4.01M |
| Q2 2022 | 14 | $5.92M |
| Q1 2022 | 12 | $5.28M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Alpha Tau Medical Ltd.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FMR LLC | 362,046 | $1.15M | 0.00% | +20,167+5.9% | Added |
| JPMorgan Chase & Co | 59,348 | $189.0K | 0.00% | −15,768−21.0% | Reduced |
| Citigroup Inc | 24,126 | $76.7K | 0.00% | −5,592−18.8% | Reduced |
| Geode Capital Management, LLC | 20,242 | $64.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 18,603 | $59.2K | 0.00% | +7,020+60.6% | Added |
| Wells Fargo & Company | 10,806 | $34.4K | 0.00% | 00.0% | Unchanged |
| Summit Trail Advisors, LLC | 10,270 | $32.7K | 0.00% | +10,270 | New |
| Financial Guidance Group, Inc. | 10,260 | $32.6K | 0.03% | 00.0% | Unchanged |
| Opal Wealth Advisors, LLC | 10,000 | $31.8K | 0.02% | +10,000 | New |
| Tower View Investment Management & Research LLC | 5,566 | $18.0K | 0.01% | 00.0% | Unchanged |
| UBS Group AG | 1,546 | $4.92K | 0.00% | +1,546 | New |
| Royal Bank of Canada | 1,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| Phoenix Holdings Ltd. | 10,141 | $33 | 0.00% | −3,719−26.8% | Reduced |
| Bank of America Corp | 10 | $32 | 0.00% | 00.0% | Unchanged |
| ETF Managers Group, LLC | 0 | $0 | 0.00% | −96,060−100.0% | Sold out |
| Wealthspire Advisors, LLC | 0 | $0 | 0.00% | −22,632−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −22,481−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −19,016−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −6,269−100.0% | Sold out |
| Tuttle Tactical Management | 0 | $0 | 0.00% | −10,778−100.0% | Sold out |
| Highbridge Capital Management LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |